Bioharvest Sciences Inc (BHSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 357 | 202 | 216 | 217 | 209 |
| Accounts receivable | -75 | -213 | -141 | -3 | -31 |
| Other Working Capital | 344 | -496 | -299 | 738 | -288 |
| Other Operating Activity | -1,584 | -1,071 | -2,770 | -1,947 | -2,768 |
| Operating Cash Flow | $-958 | $-1,578 | $-2,994 | $-995 | $-2,878 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,708 | -222 | -291 | -440 | -367 |
| Other Investing Activity | -225 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,933 | $-222 | $-291 | $-440 | $-367 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | N/A | 1,278 | 4,440 |
| Debt Repayment | -119 | -129 | -90 | -95 | -96 |
| Other Financing Activity | 4,725 | 13 | 7,099 | 0 | 403 |
| Financing Cash Flow | $4,606 | $-116 | $7,009 | $1,183 | $4,747 |
| Exchange Rate Effect | 17 | -3 | 72 | -1 | 10 |
| Beginning Cash Position | 3,436 | 5,355 | 1,559 | 1,812 | 300 |
| End Cash Position | 5,168 | 3,436 | 5,355 | 1,559 | 1,812 |
| Net Cash Flow | $1,715 | $-1,916 | $3,724 | $-252 | $1,502 |
| Free Cash Flow | |||||
| Operating Cash Flow | -958 | -1,578 | -2,994 | -995 | -2,878 |
| Capital Expenditure | -1,708 | -222 | -291 | -440 | -367 |
| Free Cash Flow | -2,666 | -1,800 | -3,285 | -1,435 | -3,245 |